表紙:ヒト初代細胞市場:製品タイプ別、分離別、細胞タイプ別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
市場調査レポート
商品コード
1299773

ヒト初代細胞市場:製品タイプ別、分離別、細胞タイプ別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Human Primary Cells Market with COVID-19 Impact Analysis, By Product Type, By Separation, By Cell Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 323 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.86円
ヒト初代細胞市場:製品タイプ別、分離別、細胞タイプ別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年07月01日
発行: AnalystView Market Insights
ページ情報: 英文 323 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートのハイライト

ヒト初代細胞の市場規模は2022年に13億6,070万米ドルとなり、2023年から2030年にかけてCAGR 11.5%で拡大

ヒト初代細胞市場-市場力学:

初代細胞市場の成長の背景には、高齢者人口の増加、研究開発の進展、慢性疾患患者の増加があります。また、医薬品市場は高度な検査や医薬品開発で大きく成長しています。このため、ヒト初代細胞市場の採用が増加すると予測されています。しかし、原材料の利用制限や高価なプロセスが、予測期間中の市場成長を妨げる主な要因となっています。

さらに、プライマリー細胞培養は新薬の細胞毒性を同定するために使用されます。さらに、ヒト初代細胞は、化学物質、化粧品、新薬の効果を試験するために、動物モデルの代わりに使用されます。これらは市場成長を促進すると予想される主な要因です。COVID-19パンデミックはヒト初代細胞市場にプラスの影響を与えています。ヒト初代細胞は、感染症を理解するために研究者によって使用されます。特性化され標準化された上皮細胞培養モデルは、コロナウイルスによって破壊された物理的バリアを理解するのに役立っています。このモデルは呼吸器の特性や機能を模倣するのに役立ち、研究成果を医療応用につなげる突破口となります。

ヒト初代細胞市場-セグメンテーション分析:

世界のヒト初代細胞市場は、製品タイプ、分離、細胞タイプ、用途、地域に基づいてセグメント化されます。

製品タイプにより市場は3つに分類される:ヒト初代細胞、試薬とサプリメント、培地です。試薬とサプリメントの分野が市場を占有すると予想されます。ヒト初代細胞は、試薬およびサプリメントの製造および研究における日常的な応用に関与しています。試薬とサプリメントは、ヒト初代細胞が成長するために壊れやすいため、非常に重要であると考えられています。

市場は分離に基づき、摘出法、酵素分解法、機械的分離法、その他に分けられます。酵素分解法は、予測期間中も優位性を維持しそうです。これは、ヒト初代細胞の分離において、比較的迅速で、代表的なサンプルの収量が高く、培養物へのダメージが少ないなどの利点があるため、他の技術に代わって酵素分解法が高く評価されていることが一因です。

市場は細胞タイプによって動物用とヒト用に分けられます。動物分野が最大の市場シェアを占めると予想されます。ワクチン開発のために、動物由来のヒト初代細胞の用途が増加していることが、同分野の成長を促進する重要な要因となっています。

市場は用途別に、組織培養・組織工学、ワクチン製造、遺伝子治療・再生医療、毒性試験・薬剤スクリーニング、ウイルス学、がん研究、幹細胞治療、モデルシステム、出生前診断、その他の9カテゴリーに分類されます。予測期間中、ワクチン生産分野が市場を独占すると予想されます。B型肝炎や麻疹を含む様々なワクチンの生産に利用されるウイルスの生産に、動物初代培養の利用が増加しています。

ヒト初代細胞市場-競合情勢:

ヒト初代細胞市場は、様々な免疫不全疾患の治療にヒト初代細胞を利用することで、より良い治療法を開発するための研究開発活動への旺盛な投資により、世界的に急速に拡大しています。また、バイオ医薬品やバイオテクノロジー分野の成長に伴い、医学研究者は悪性がんの治療にヒトや動物の組織から採取したヒト初代細胞を使用する研究を続けています。さらに、主要企業は市場収益を高めるため、新製品の発売、M&A、研究開発費、パートナーシップ、提携などの戦略を採用しています。例えば、2021年8月、Axol Bioscience LtdはCENSO Biotechnologiesとの合併を発表しました。合併後の事業体は、サービス・ソリューションと製品のリーディング・プロバイダーとなります。さらに、検証済みのすぐに使える細胞株や、強固な機能データ、カスタマイズ機能、幅広い専門知識を備えた一連のサービスを、リードタイムを短縮して顧客に提供することになります。

研究の主な特徴

ヒト1次細胞市場に関するこの調査レポートは、2022年を基準年として、市場規模、複合年間成長率(CAGR %)、推定・予測(2023-2030年)を提供します。

この調査レポートは、異なるセグメント/国にわたる潜在的な成長機会を解明し、ヒト初代細胞市場の魅力的な投資提案マトリクスを説明しています。

全体的なレポートでは、新規投資機会、既存企業が直面する課題、ヒト初代細胞市場で持続するための成長要因を特定しています。

COVID-19がヒト初代細胞市場規模、予測、CAGR、市場力学に与える影響については、調査範囲で詳細に論じています。COVID後のヒト初代細胞市場に関する詳細な洞察もカバーします。

本レポートのユーザーにヒト一次細胞市場の包括的な見解を提供するために、ヒト一次細胞市場の競合情勢と主要イノベーター分析も含めています。

本レポートでは、市場規模、成長率、魅力度に基づいてすべての業界セグメントをベンチマークする、成長見通しマッピング分析を網羅しています。

本レポートは、主要な市場参加企業を特集した詳細な企業プロファイルを提供しており、ヒト初代細胞市場で事業を展開する企業の財務情報や戦略的イニシアチブを理解するのに役立ちます。

また、本レポートでは、世界レベルだけでなく、地域レベルで市場に関与する主要参入企業の重要な買収&合併、提携&ジョイントベンチャー、新発売、研究開発、地域展開についても明らかにしています。

ヒト一次細胞の世界市場レポートは主に、サプライヤー、投資家、新規参入者、流通業者、金融アナリストなど、この業界の様々な利害関係者を対象としています。

目次

第1章 ヒト初代細胞市場概要

  • 調査範囲

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ヒト初代細胞の主要な市場動向

  • ヒト初代細胞市場促進要因
  • ヒト初代細胞市場抑制要因
  • ヒト初代細胞の市場機会
  • ヒト初代細胞市場の今後の動向

第4章 ヒト初代細胞産業の研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 ヒト初代細胞市場:COVID-19の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 ヒト初代細胞市場情勢

  • ヒト初代細胞市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 確立された企業の分析
    • 新興企業の分析

第7章 ヒト初代細胞市場-製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • ヒト初代細胞
    • 試薬とサプリメント
    • メディア

第8章 ヒト初代細胞市場- 分離別

  • 概要
    • セグメント別のセグメントシェア分析
    • 外植法
    • 酵素分解
    • 機械的分離
    • その他

第9章 ヒト初代細胞市場- 細胞タイプ別

  • 概要
    • セルタイプ別のセグメントシェア分析
    • 動物
    • 人間

第10章 ヒト初代細胞市場- 用途別

  • 概要
    • 用途別のセグメントシェア分析
    • 組織培養と組織工学
    • ワクチンの生産
    • 遺伝子治療と再生医療
    • 毒性試験と薬物スクリーニング
    • がん調査
    • 幹細胞療法
    • モデルシステム
    • 出生前診断
    • その他

第11章 ヒト初代細胞市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • ヒト初代細胞北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • ヒト初代細胞欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋(APAC)
    • 概要
    • ヒト初代細胞アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ヒト初代細胞ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • ヒト初代細胞中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析- ヒト初代細胞産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Merck Group
    • ATCC
    • Thermo Fisher Scientific Inc
    • Sigma-Aldrich Co.
    • Charles River Laboratories
    • Merck Group
    • Axol Bioscience
    • ReachBio Research Labs
    • STEMCELL Technologies Inc
    • Lonza
    • Cell Biologics, Inc.
    • PromoCell-Human Centered Science
    • ZenBio, Inc.
    • AllCells

第13章 アナリストの全方位的展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Human Primary Cells Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Human Primary Cells Market, by Product Type2018-2030 (USD Million)
  • TABLE Human Primary Cells Market: SeparationSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Separation
  • TABLE Global Human Primary Cells Market, by Separation2018-2030 (USD Million)
  • TABLE Human Primary Cells Market: Regional snapshot (2022)
  • TABLE Human Primary Cells Market: Cell Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Cell Type
  • TABLE Global Human Primary Cells Market, by Cell Type 2018-2030 (USD Million)
  • TABLE Human Primary Cells Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Human Primary Cells Market, by Application2018-2030 (USD Million)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Human Primary Cells Market, by Region 2018-2030 (USD Million)
  • TABLE North America Human Primary Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Human Primary Cells Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Human Primary Cells Market, by Separation, 2018-2030 (USD Million)
  • TABLE North America Human Primary Cells Market, by Cell Type, 2018-2030 (USD Million)
  • TABLE North America Human Primary Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Human Primary Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Human Primary Cells Market, by Product Type, 2018-2030 (USD Million)
  • TABLE EuropeHuman Primary Cells Market, by Separation, 2018-2030 (USD Million)
  • TABLE Europe Human Primary Cells Market, by Cell Type, 2018-2030 (USD Million)
  • TABLE Europe Human Primary Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Primary Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Primary Cells Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Primary Cells Market, by Separation, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Primary Cells Market, by Cell Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Primary Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Human Primary Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Human Primary Cells Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Human Primary Cells Market, by Separation, 2018-2030 (USD Million)
  • TABLE Latin America Human Primary Cells Market, by Cell Type, 2018-2030 (USD Million)
  • TABLE Latin America Human Primary Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Primary Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Primary Cells Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Primary Cells Market, by Separation, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Primary Cells Market, by Cell Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Primary Cells Market, by Application, 2018-2030 (USD Million)
目次
Product Code: ANV1363

REPORT HIGHLIGHT

Human Primary Cells market size was valued at USD 1,360.7 Million in 2022, expanding at a CAGR of 11.5% from 2023 to 2030.

Human Primary Cells are also known as mature cells extracted from living tissues of humans and animals after that processed to establish them for utilization in appropriate cell therapies. Additionally, Human Primary Cells are also used in several applications such as cancer research, 3D cell culture, tissue replacement, stem cell therapy, and virology. 3D cell culture is increasingly used by researchers to study cell biology and biochemistry, cell-pathogen interactions, drug effects, and cell signaling.

Human Primary Cells Market- Market Dynamics:

The primary cell market growth is attributed to the increasing geriatric population, advancements in development and research, and a rise in cases of chronic diseases. Additionally pharmaceutical market is growing significantly in advanced testing and drug development. This in turn projected to facilitate increased adoption of the Human Primary Cells market. However, restrictions implemented for the utilization of raw materials and expensive processes are the major factors hindering the market growth during the forecast period.

Moreover, primary cell cultures are used to identify the cytotoxicity of new drugs. Furthermore, Human Primary Cells are used in the place of animal models to test the effects of chemicals, cosmetics, and new drugs. These are some major factors expected to drive market growth. The COVID-19 pandemic has impacted the Human Primary Cells market positively. Human Primary Cells are used by researchers for understanding the infection. Characterized and standardized epithelium cell culture models are helping to understand the physical barrier devastated by the coronavirus. The models can assist mimic the properties and functions of the respiratory tract which leads to a breakthrough for a research outcome moving into a medical application

Human Primary Cells Market- Segmentation Analysis:

The global Human Primary Cells market is segmented on the basis of product type, separation, cell type, application, and region.

The market is divided into three categories based on product type: Human Primary Cells, reagents and supplements, and media. The reagents and supplements sector is expected to possess the market. Human Primary Cells are involved in reagents and supplements' routine application in manufacturing and research. The reagents and supplements are considered very crucial as Human Primary Cells are fragile for their growth.

The market is divided into three categories based on separation: explant method, enzymatic degradation, mechanical separation, and others. The enzymatic degradation sector is likely to maintain its dominance during the forecast period. This is partly due to its high preference at the place of other techniques for the separation of Human Primary Cells owing to its advantages such as comparatively fast, high yield of a representative sample, and less damage to cultures.

The market is divided into two categories based on cell type: animal and human. The animal sector is expected to hold the largest market share. For vaccine development, increasing the application of animal-origin Human Primary Cells are essential factor propelling the segment growth.

The market is divided into nine categories based on application: tissue culture & tissue engineering, vaccine production, gene therapy and regenerative medicine, toxicity testing & drug screening, virology, cancer research, stem cell therapy, model system, prenatal diagnosis, and others. The vaccine production sector is expected to dominate the market over the forecast period. Rising use of primary animal culture for the production of virus that is later utilized for producing various vaccines including hepatitis B and measles.

Human Primary Cells Market-Competitive Landscape:

The Human Primary Cells market is rapidly driven globally by robust investment in research and development activities for the increment of better therapies where Human Primary Cells can be utilized to treat various immunodeficiency disorders. Additionally, with The growth in biopharmaceutical and biotechnology sectors, medical researchers are continuously working on using Human Primary Cells from human and animal tissues for the treatment of malignant cancers. Moreover, key players are adopting strategies such as new product launches, mergers & acquisitions, R&D spending, partnerships, and collaboration to enhance their market revenue. For instance, in August 2021, Axol Bioscience Ltd announced its merger with CENSO Biotechnologies. The merged entity will become a leading provider of service solutions and products. Additionally, it will provide customers with validated ready-to-use cell lines and a suite of services with robust functional data, customization capabilities, and broader expertise, all with shorter lead times.

Key features of the study:

This proposed research study on Human Primary Cells market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Human Primary Cells market.

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Human Primary Cells market.

Impact of COVID-19 on Human Primary Cells market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Human Primary Cells market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the Human Primary Cells market, we have also included competitive landscape and key innovator analysis for Human Primary Cells market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offersdetailed company profiling featuring major market participantswhich will help users to understand their financial information and strategic initiatives of players operating in the Human Primary Cells market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.

The global Human Primary Cells market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HUMAN PRIMARY CELLS MARKET KEY PLAYERS

  • Merck Group
  • ATCC
  • Thermo Fisher Scientific Inc
  • Sigma-Aldrich Co.
  • Charles River Laboratories
  • Merck Group
  • Axol Bioscience
  • ReachBio Research Labs
  • STEMCELL Technologies Inc
  • Lonza
  • Cell Biologics, Inc.
  • PromoCell - Human Centered Science
  • ZenBio, Inc.
  • AllCells

GLOBAL HUMAN PRIMARY CELLS MARKET, BY PRODUCT TYPE

  • Human Primary Cells
  • Reagents and Supplements
  • Media

GLOBAL HUMAN PRIMARY CELLS MARKET, BY SEPARATION

  • Explant Method
  • Enzymatic Degradation
  • Mechanical Separation
  • Others

GLOBAL HUMAN PRIMARY CELLS MARKET, BY CELL TYPE

  • Animal
  • Human

GLOBAL HUMAN PRIMARY CELLS MARKET, BY APPLICATION

  • Tissue Culture & Tissue Engineering
  • Vaccine Production
  • Gene Therapy and Regenerative Medicine
  • Toxicity Testing and Drug Screening
  • Cancer Research
  • Stem Cell Therapy
  • Model System
  • Prenatal Diagnosis
  • Others

GLOBAL HUMAN PRIMARY CELLS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Human Primary Cells Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Human Primary Cells Market Snippet by Product Type
    • 2.1.2. Human Primary Cells Market Snippet by Separation
    • 2.1.3. Human Primary Cells Market Snippet by Cell Type
    • 2.1.4. Human Primary Cells Market Snippet by Application
    • 2.1.5. Human Primary Cells Market Snippet by Country
    • 2.1.6. Human Primary Cells Market Snippet by Region
  • 2.2. Competitive Insights

3. Human Primary Cells Key Market Trends

  • 3.1. Human Primary Cells Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Human Primary Cells Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Human Primary Cells Market Opportunities
  • 3.4. Human Primary Cells Market Future Trends

4. Human Primary Cells Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Human Primary Cells Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Human Primary Cells Market Landscape

  • 6.1. Human Primary Cells Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Human Primary Cells Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022&2030 (%)
    • 7.1.2. Human Primary Cells
    • 7.1.3. Reagents and Supplements
    • 7.1.4. Media

8. Human Primary Cells Market - By Separation

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Separation, 2022&2030 (%)
    • 8.1.2. Explant Method
    • 8.1.3. Enzymatic Degradation
    • 8.1.4. Mechanical Separation
    • 8.1.5. Others

9. Human Primary Cells Market - By Cell Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Cell Type, 2022&2030 (%)
    • 9.1.2. Animal
    • 9.1.3. Human

10. Human Primary Cells Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 10.1.2. Tissue Culture & Tissue Engineering
    • 10.1.3. Vaccine Production
    • 10.1.4. Gene Therapy and Regenerative Medicine
    • 10.1.5. Toxicity Testing and Drug Screening
    • 10.1.6. Cancer Research
    • 10.1.7. Stem Cell Therapy
    • 10.1.8. Model System
    • 10.1.9. Prenatal Diagnosis
    • 10.1.10. Others

11. Human Primary Cells Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Human Primary Cells Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Human Primary Cells Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Human Primary Cells Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Human Primary Cells Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Human Primary Cells Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Human Primary Cells Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Merck Group
    • 12.2.2. ATCC
    • 12.2.3. Thermo Fisher Scientific Inc
    • 12.2.4. Sigma-Aldrich Co.
    • 12.2.5. Charles River Laboratories
    • 12.2.6. Merck Group
    • 12.2.7. Axol Bioscience
    • 12.2.8. ReachBio Research Labs
    • 12.2.9. STEMCELL Technologies Inc
    • 12.2.10. Lonza
    • 12.2.11. Cell Biologics, Inc.
    • 12.2.12. PromoCell - Human Centered Science
    • 12.2.13. ZenBio, Inc.
    • 12.2.14. AllCells

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us